Although several studies on cyclin D1 expression have been actively conducted before, considering the application of CDK4/6 inhibitors in CRC, cyclin D1-related studies in SIAC remain limited and rudimentary, owing to the rarity of the disease. This evidence concerns the gene CCND1 and colorectal carcinoma.